GlassScriptPhysician profile
Irina S Addes
NPI 1659436533
$2,651.81
in general payments reported to CMS, 2019-2025
21 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,592 · 2020: $408 · 2021: $343 · 2023: $163 · 2024: $20.75 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.36 | 2021-2024 | Vraylar |
| Alkermes, INC. | $296.89 | 2019-2023 | Aristada, Aristada Initio |
| Sunovion Pharmaceuticals INC. | $263.34 | 2019-2021 | |
| Allergan, INC. | $257.45 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $235.41 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $196.86 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $182.98 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $125.32 | 2019 | |
| Axsome Therapeutics, INC. | $125.00 | 2025 | Auvelity |
| Bausch Health US, LLC | $121.98 | 2019-2020 | |
| Lundbeck LLC | $105.06 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $92.09 | 2019-2020 | |
| Neos Therapeutics, LP | $77.40 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $60.92 | 2019 | |
| Supernus Pharmaceuticals, INC. | $45.71 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $36.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $29.78 | 2019 | |
| Ironshore Pharmaceuticals INC. | $23.01 | 2019 | |
| Corium, LLC | $19.04 | 2023 | Azstarys |
| Adlon Therapeutics L.P. | $12.57 | 2020 | |
| Tris Pharma INC | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Addes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.